A new study by researchers at the Bellvitge Biomedical Research Institute (IDIBELL) has found a cause of multiple resistance in cancer chemotherapy. The work, published today in the Proceedings...
Researchers of the Cellular Differentiation Group at the Epigenetics and Cancer Biology Program at IDIBELL, led by researcher Maribel Parra, have identified a transcriptional repressor, the histone...
Salk scientists, in collaboration with Dr. Josep Maria Campistol, CEO and nephrologist of Hospital Clínic and Marta Lazo, IDIBAPS researcher, have managed to create and maintain renal...
Multicomponent reactions are protocols that ease the chemical synthesis of new compounds, and are particularly important to gain molecules with biological activity as therapeutic agents against...
Dr Manel Esteller, leader of the Cancer Epigenetics and Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and University of Barcelona...
An article published in Nature Biotechnology shows that epigenetic tests have the same technical quality and accuracy than genetic tests. This was the conclusion of the results-that were...
A team of researchers elaborated a computational method to track the progress of the colorectal cancer. It is a scientific advance that can bring new perspectives to discover the factors that push...
Migraine is one of the most common neurological disorders and it affects 1 out of 7 people in the world. Painful and incapacitating, it has multi-factor origins, with the participation of...
Rewarding learning today can improve learning tomorrow; this is one of the conclusions reached by researchers from the Cognition and Brain Plasticity research group of the Institute of...
The academic year 2016-17 launches the university Master’s degree in emotional care to hospitalized children according to the Child Life model which will be presented on June 14 to the...